Retinoids and retinoic acid receptors regulate growth arrest and apoptosis in human mammary epithelial cells and modulate expression of CBP/p300

Microscopy Research and Technique

Volumn 59, Issue 1, 2002, Pages 23-40

  Dietze, Eric C ^a   Elizabeth Caldwell, L ^b   Marcom, Kelly ^a   Collins, Steven J ^b   Yee, Lisa ^c   Swisshelm, Karen ^d   Hobbs, Katherine B ^a   Bean, Gregory R ^a   Seewaldt, Victoria L ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

CBP; Extracellular matrix; Mammary epithelial cells; p300; Retinoic acid receptor

Indexed keywords

CANCER CELLS; CHEMICAL ACTIVATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; PROTEINS;

CREB-BINDING PROTEIN; DOMINANT NEGATIVE; EXTRACELLULAR MATRICES; GROWTH ARREST; HUMAN MAMMARY EPITHELIAL CELLS; MAMMARY EPITHELIAL CELLS; P300; RETINOIC ACID RECEPTORS; RETINOID ACIDS; RETINOIDS;

CELL DEATH;

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; PROTEIN P300; RETINOIC ACID RECEPTOR; RETINOID;

APOPTOSIS; ARTICLE; BREAST EPITHELIUM; CELL GROWTH; EXTRACELLULAR MATRIX; GENETIC TRANSCRIPTION; HOMEOSTASIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0036786819     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jemt.10174     Document Type: Article

References (58)

1. Alford D, Baeckström D, Geyp M, Pitha P, Taylor-Papadimitriou J. 1998. Integrin-matrix interactions affect the form of the structures developing from human mammary epithelial cells in collagen or fibrin gels. J Cell Sci 111:521-532.
2. Altucci L, Gronemeyer H. 2001. The promise of retinoids to fight against cancer. Nature Rev. Cancer 1:181-193.
3. Anderson B, Rosenfield MG. 1995. New wrinkles in retinoids. Nature 374:118-119.
4. Aubele M, Cummings M, Walch A, Zitzelsberger H, Nahrig J, Hofler H, Werner M. 2000 Heterogeneous chromosomal aberrations in intraductal breast lesions adjacent to invasive carcinomas. Anal Cell Pathol 20:7-24.
5. Berard J, Laboune F, Mukuna M, Masse S, Kothary R, Bradley WE. 1994. Hyperplasia and tumors in lung, breast, and other tissues in mice carrying a RARβ4-like transgene. EMBO J 13:5570-5580.
6. Damm K, Heyman RA, Umesono K, Evans RM. 1993. Functional inhibition of retinoic acid response by dominant negative retinoic acid receptor mutants. Proc Natl Acad Sci USA 90:2989-2993.
7. Deng G, Lu Y, Zlotnikov G, Thor AD, Smith H. 1996. Loss of heterozygocity in normal tissues adjacent to breast carcinomas. Science 274:2057-2059.
8. DeThe H, del Mar Vivanco-Ruiz M, Tiollais P, Stunnenberg H, Dejean, A. 1990. Identification of a retinoic acid responsive element in the retinoic acid receptor-β gene. Nature 343:177-180.
9. Dietze EC, Yee L, Seewaldt VL. 2000. Suppression of pRB expression in normal human mammary epithelial cells is associated with resistance to all-trans-retinoic acid but not N-(4-hydroxyphenyl)-retinamide. Breast Cancer Res Treat 66:41-50.
10. Evans G, Littlewood T. 1998. A matter of life and cell death. Science 281:1317-1322.
11. Folkman J, Moscona A. 1978. Role of cell shape in growth control. Nature 273:345-349.
12. Giles RH, Peters DJM, Breuning MH. 1998. Conjunction dysfunction: CBP/p300 in human disease. Trends Genet 14:178-183.
13. Goldman PS, Tran VK, Goodman RH. 1997. The multifunctional role of the co-activator CBP in transcriptional regulation. Recent Prog Horm Res 52:103-120.
14. Hayashi K, Yokozari H, Naka K, Yasui W, Yajin K, Lotan R, Tahara E. 2000. Effect of 9-cis-retinoic acid on oral squamous cell carcinoma cell lines. Cancer Lett 151:199-208.
15. Hayashi K, Yokozaki H, Naka K, Yasui W, Lotan R Tahara, E. 2001. Overexpression of retinoic acid receptor beta induces growth apprest and apoptosis in oral cancer cell lines. Jpn J Cancer Res 92:42-50.
16. Hoffmann B Lehmann JM, Zhang X-K, Hermann T, Husmann M, Graupner G, Pfahl M. 1990. A retinoic acid receptor-specific element controls the retinoic acid receptor-β promoter. Mol Endocrinol 4:1727-1736.
17. Holtz MA, Del Bino G, Lassota P, Traganos F, Darzynkiewicz Z. 1992. Cytostatic and cytotoxic effects of fostriecin on human promyleocytic HL-60 and lymphocytic MOLT-4 cells. Cancer Res 52:530-1535.
18. Hong WK, Sporn MB. 1997. Recent advances in chemoprevention. Science 278:1073-1077.
19. Hunter DJ, Manson JE, Colditz GA, Stampfer MJ, Rosner B, Hennekens CH, Speizer FE, Willett WC. 1993. A prospective study of the intake of vitamins C, E, and A and the risk of breast cancer. N Engl J Med 329:234-240.
20. Imakado S, Bickenbach JR, Bundman DS, Rothnagel JA, Attar PS, Wang X-J, Walcznak VR, Wisniewski S, Pote J, Gordon JS, Heyman RA, Evans RM, Roop DR. 1995. Targeting expression of a dominant-negative retinoic acid receptor mutant in the epidermis of transgenic mice results in loss of barrier function. Genes Dev 9:317-328.
21. Kastner P, Grondona JM, Mark M, Gansmuller A, Le Mur M, Decimo D, Vonesch J-L, Dolle P, Chambon P. 1994. Genetic analysis of RXR alpha developmental function: convergence of RXR and RAR signaling pathways in heart and eye morphogenesis. Cell 78:987-1003.
22. Kato J-Y, Matsushime H, Hiebert SW, Ewen ME, Sherr CJ. 1993. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev 7:331-342.
23. Kawasaki H, Eckner R, Yao TP, Taira K, Chiu R, Livingston DM, Yokoyama KK. 1998. Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F-9 cell differentiation. Nature 393:284-289.
24. Langenfield J, Kiyokawa H, Sekula D, Boyle J, Dmitrosvsky E. 1997. Posttranslational regulation of cyclin D1 by retinoic acid: a chemoprevention mechanism. Proc Natl Acad Sci USA 94:12070-12074.
25. Li M, Chiba H, Warot X, Messaddeq N, Gerard C, Chambon P, Metzger D. 2001. RXR-alpha ablation in skin keratinogytes results in alopecia and epidermal alterations. Development 128:675-688.
26. Linninger RA, Park W-S, Man Y-G, Pham T, MacGrogan G, Zhuang Z, Tavassoli FA. 1998. LOH at 16p13 is a novel chromosomal alteration detected in benign and malignant microdissected papillary neoplasms of the breast. Hum Pathol 29:1113-1118.
27. Lippmann SM, Bataskis JG, Toth BB, Weber RS, Lee JJ, Martin JW, Hays GL, Goepfert H, Hong WK. 1993. Comparison of low-dose isotretinoin with beta-carotene to prevent oral carcinogenesis. N Engl J Med 328:15-20.
28. Liu Y, Lee M-O, Wang H-G, Li Y, Hashimoto Y, Klaus M, Reed JC, Zhang X-K. 1996. Mol Cell Biol 16:1138-1149.
29. Lu YJ, Osin P, Lakhani SR, Di Palma S, Gusterson BA, Shipley JM. 1998. Comparative genomic hybridization analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic materials in breast neoplasia. Cancer Res 58:4712-4727.
30. Mancini M, Anderson BO, Caldwell, LE, Sedghinasab M, Paty PB, Hockenbery DM. 1997. Mitochondrial proliferation and paradoxical membrane depolarization during terminal differentiation and apoptosis in a human colon cancer cell line. J Cell Biol 128:449-469.
31. Mendelsohn C, Mark P, Dolle P, Dieerich A, Gaub MP, Krust A, Lampron C, Chambon P. 1994. Retinoic acid receptor β2 (RARβ2) null mutant mice appear normal. Dev Biol 166:246-258.
32. Nagpal S, Zelent A, Chambon P. 1992. RAR-β4, a retinoic acid receptor isofom is generated from RARβ2 by alternative splicing and usage of a CUG initiator codon. Proc Natl Acad Sci USA 89:2718-2722.
33. Oshahi H, Ichikawa A, Takagi H, Hotta T, Naoe T, Ohno R, Siato H. 1992. Remission induction of acute promyelocytic leukemia by alltrans-retinoic acid: molecular eveidence of restoration of normal hematopoisis after differentiation and subsequent extinction of leukemic clone. Leukemia 6:859-862.
34. Park J, Robertson K, Hickstein D, Tsai S, Hockenbery D, Collins S. 1994. Dysregulated bcl-2 expression inhibits apoptosis but not differentiation of retinoic acid induced HL-60 granulocytes. Blood 84:440-445.
35. Petersen OW, Rønnov-Jessen L, Howlett AR, Bissell MJ. 1992. Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proc Natl Acad Sci USA 89:9064-9068.
36. Robyr D, Wolffe AP, Wahi W. 2000. Nuclear hormone receptor coregulators in action: diversity for shared tasks. Mol Endocrinol 14:329-347.
37. Saitou M, Sugai S, Tanaka T, Shimouchi K, Fuchs E, Narumiya S, Kakizuka A. 1995 Inhibition of skin development by targeted expression of a dominant-negative retinoic acid receptor. Nature 374:159-162.
38. Seewaldt VL, Johnson BS, Parker MB, Collins SJ, Swisshelm KS. 1995. Expression of retinoic acid receptor β mediates retinoid-induced growth arrest and apoptosis in breast cancer cells. Cell Growth Differ 6:1077-1088.
39. Seewaldt VL, Kim J-H, Caldwell LE, Johnson BS, Swisshelm K, Collins SJ. 1997a. All-trans-retinoic acid mediates G1 arrest but not apoptosis of normal human mammary epithelial cells. Cell Growth Differ 8:631-641.
40. Seewaldt VL, Caldwell LE, Johnson BS, Swisshelm K, Collins SJ, Tsai S. 1997b. Inhibition of retinoic acid receptor function in normal human mammary epithelial cells results in increased cellular proliferation and inhibits the formation of a polarized epithelium in vitro. Exp Cell Res 236:16-28.
41. Seewaldt VL, Kim J-H, Parker MB, Dietze EC, Srinivasan KV, Caldwell LE. 1999a. Dysregulated expression of cyclin D1 in normal human mammary epithelial cells inhibits all-trans-retinoic acid-mediated G0/G1-phase arrest and differentiation in vitro. Exp Cell Res 249:70-85.
42. Seewaldt VL, Dietze EC, Johnson BS, Collins SJ, Parker MB. 1999b. G1/S-phase arrest mediated by all-trans-retinoic acid in normal human mammary epithelial cells is independent of p53 expression. Cell Growth Differ 10:49-59.
43. Snowden AW, Perkins ND. 1998. Cell cycle regulation of the transcriptional coactivators p300 and CREB binding protien. Biochem Pharmacol 55:1947-1954.
44. Sommer KM, Chen LI, Treuting PM, Smith LT, Swisshelm K. 1999. Elevated retinoic acid receptor beta (4) protein in human breast tumor cells with nuclear and cytoplasmic localization. Proc Natl Acad Sci USA 96:8651-8656.
45. Soprano DR, Gyda M, Jiang H, Harnish DC, Ugen K, Satre M, Kochhar DM. 1994. A sustained elevation in retinoic acid receptor-beta2 mRNA and protein occurs during retinoic acid induced fetal dysmorphogenesis. Mech Dev 45:243-253.
46. Sun S-Y, Wan H, Yue P, Hong WK, Lotan R. 2000. Evidence that retinoic acid receptor induction by retinoids is important for tumor cell growth inhibition. J Biol Chem 275:17149-17153.
47. Swisshelm K, Ryan K, Lee X, Tsou HC, Peacocke M, Sager R. 1994. Down-regulation of a retinoic acid receptor-β in mammary carcinoma cell lines and its up-regulation in senescing normal mammary epithelial cells. Cell Growth Diff 5:133-141.
48. Tanaka Y, Naruse I, Maekawa T, Masuya H, Shiroshi T, Ishi S. 1997. Abnormal skeletal patterning in embryos lacking a single Cbp allele: a partial similarity with Rubinstein-Taybi syndrome. Proc Natl Acad Sci USA 94:10215-10220.
49. Tepper CG, Studzinski GP. 1992. Teniposide induces nuclear but not mitochondrial DNA degradation. Cancer Res 52:3384-3390.
50. Thompson CB. 1995. Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-1462.
51. Tsai S, Collins SJ. 1993. A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocytic stage. Proc Natl Acad Sci USA 90:7153-7157.
52. Tsai S, Bartelmez S, Heyman R, Damm K, Evans R, Collins SJ. 1992. A mutated retinoic acid receptor-alpha exhibiting dominant-negative activity alters the lineage development of a mulitpotent hematopoietic cell line. Genes Dev 6:2258-2269.
53. Tsai S, Bartelmez S, Sitnicka E, Collins S. 1994. Lymphohematopoietic progenitors immortalized by a retroviral vector harboring a dominant-negative retinoic acid receptor can recapitulate lymphoid, myeloid, and erythroid development. Genes Dev 8:2831-2841.
54. Vo N, Goodman RH. 2001. CREB-binding protein and p300 in transcriptional regulation. J Biol Chem 276:13505-13508.
55. Volkes EE, Weichselbaum RR, Lippman SM, Hong WK. 1993. Head and neck cancer. N Engl J Med 328:184-194.
56. Widschwendter M, Berger J, Daxenbichler G, Müller-Holzner E, Widshwendter A, Mayr A, Marth C, Zeimet AG. 1997. Loss of retinoic acid receptor beta expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer. Cancer Res 57:4158-4161.
57. Xu XC, Sneige N, Liu X, Nandagiri R, Lee JJ, Lukamanji F, Horrtobagi G, Lippman SM, Dhingra K, Lotan R. 1997. Progressive decrease in nuclear retinoic acid receptor beta messenger RNA during breast carcinogenesis. Cancer Res 57:4992-4996.
58. Yao TP, Oh SP, Fuchs M, Zhou ND, Ch'ng LE, Newsome D, Bronson RT, Livingston DM, Eckner R. 1998. Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 93:361-372.